The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•16 April 2026•

1 min read

Aspire Biopharma Expands Retail Footprint via Strategic Brokerage Partnership

A world map in golden tones with overlaid financial charts showing a downward trend, a large blue arrow pointing down, and falling circuit boards and text. Two screens display NASDAQ data.

Key Facts

1Aspire Biopharma's subsidiary Buzz Bomb signed a strategic brokerage agreement with Interwest Brokerage.

2The partnership aims to accelerate expansion across grocery and convenience channels in the Intermountain West region.

Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP) announced that its subsidiary, Buzz Bomb Caffeine Company, has entered into a strategic brokerage agreement with Interwest Brokerage. The partnership is designed to accelerate the brand's expansion across grocery and convenience store channels specifically within the Intermountain West region. By leveraging Interwest’s extensive brokerage expertise, Aspire Biopharma aims to penetrate major retail and alternate distribution channels in the Western United States. This collaboration marks a significant milestone in the company’s regional growth strategy and brand scaling efforts. The move is expected to drive increased product availability and strengthen the company's market position in the competitive beverage sector. Analysts view this distribution expansion as a positive growth catalyst for the Nasdaq-listed firm.